Valuation : IRIDEX Corporation

Market Cap 1.23Cr 1.06Cr 99.64L 91.03L 1.7Cr 116.2Cr 1.71Cr 12Cr 4.57Cr 60Cr 4.62Cr 4.52Cr 192.07Cr P/E 2026 *
-5.84x
P/E 2027 * -
Enterprise Value 1.23Cr 1.06Cr 99.64L 91.03L 1.7Cr 116.2Cr 1.71Cr 12Cr 4.57Cr 60Cr 4.62Cr 4.52Cr 192.07Cr EV / Sales 2026 *
0.23x
EV / Sales 2027 * 0.22x
Free-Float
61.18%
Yield 2026 *
-
Yield 2027 * -
1 day+0.04%
1 week+0.47%
Current month-1.91%
1 month-13.46%
3 months-38.28%
6 months-49.66%
Current year-37.74%
1 week 0.69
Extreme 0.691
0.74
1 month 0.69
Extreme 0.691
0.98
Current year 0.69
Extreme 0.691
1.65
1 year 0.69
Extreme 0.691
1.65
3 years 0.69
Extreme 0.691
3.65
5 years 0.69
Extreme 0.691
9.46
10 years 0.69
Extreme 0.691
16.39
Manager TitleAgeSince
Chief Executive Officer 54 01/10/2024
Director of Finance/CFO 68 18/12/2018
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 24/06/2020
Director/Board Member 54 01/09/2018
Director/Board Member 66 17/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
24/08/26 Buy

Chief Financial Officer

6,668 0.0383%
10/07/26 Free

Chief Financial Officer

2,00,000 1.1490%
10/07/26 Free

Chief Executive Officer

4,00,000 2.2980%
Change 5-day change 1-year change 3-year change Capi.($)
+0.04%+0.47%-46.23%-63.60% 1.23Cr
-1.11%-1.52%+25.18%+13.05% 23TCr
-1.76%-3.82%+4.42%-20.33% 15TCr
-0.92%-1.64%-19.37%+19.11% 13TCr
+2.34%+2.39%-55.30%-10.02% 6.8TCr
+0.31%-0.20%+11.20%+18.51% 5.17TCr
+0.49%-1.32%-17.27%-14.42% 5.02TCr
+0.42%-1.81%+17.57%+27.22% 4.23TCr
-1.04%-1.13%+36.81%+48.37% 4.06TCr
-0.44%-5.05%-16.66%+48.28% 3.31TCr
Average -0.15%-1.02%-5.96%+6.62% 7.94TCr
Weighted average by Cap. -0.58%-1.78%+1.91%+8.48%

Financials

2026 *2027 *
Net sales 5.25Cr 4.52Cr 4.25Cr 3.88Cr 7.27Cr 495.88Cr 7.29Cr 50Cr 19Cr 254.42Cr 20Cr 19Cr 819.63Cr 5.6Cr 4.82Cr 4.53Cr 4.14Cr 7.74Cr 528.51Cr 7.77Cr 54Cr 21Cr 271.16Cr 21Cr 21Cr 873.56Cr
Net income -20.86L -17.95L -16.89L -15.43L -28.86L -20Cr -28.94L -2Cr -77.44L -10Cr -78.33L -76.62L -33Cr 1T 860.5 809.61 739.58 1.38T 94.42T 1.39T 9.57T 3.71T 48.44T 3.76T 3.67T 2L
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
05/26/05 $0.7001 -0.09% 57,641
03/26/03 $0.7007 -2.83% 70,141
02/26/02 $0.7211 -1.19% 14,813
01/26/01 $0.7298 +0.86% 26,838
31/26/31 $0.7236 +2.42% 28,463
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7007USD
Average target price
2.750USD
Spread / Average Target
+292.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock